Fig. 7
From: Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer

Effects of asides trioxide and midostaurin on the crosstalk network of specific risk pathways for (a) COAD; (b) STAD; (c) KIRP; (d) THYM.
From: Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer

Effects of asides trioxide and midostaurin on the crosstalk network of specific risk pathways for (a) COAD; (b) STAD; (c) KIRP; (d) THYM.